SynthesisFrontiers in immunology2025
Driving innovations in cancer research through spatial metabolomics: a bibliometric review of trends and hotspot.
Synthesis in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed.
- Spatial ecotype in tumor immune exclusion: from spatial architecture to therapeutic strategies.Molecular cancer · 2026Review
- Integrated Spatial and Bulk Untargeted Metabolomics Characterize Location- and Histology-Associated Metabolic Heterogeneity in Colorectal Cancer.Journal of proteome research · 2026Article
- Diet-Microbiota-Immune Interactions in Hepatocellular Carcinoma: An Immunometabolic and Spatial Perspective.Nutrients · 2026Review
- Molecular Hydrogen as a Regulator of Mitochondrial Quality Control and Metabolic Reprogramming.International journal of molecular sciences · 2026Review
- Targeting the immunological synapse in multiple myeloma.Discover oncology · 2026Review
- Review
- Mapping research trends in immune cell metabolic reprogramming in breast cancer: a parallel dual-database bibliometric study.Discover oncology · 2026Article
- Cancer Metabolism and Its Historical & Molecular Foundations: An Overview.Drugs and drug candidates · 2026Article
- Assessment of Tumor Margin and Heterogeneity of Colorectal Cancer Using Imaging Mass Spectrometry and Image Segmentation.Cancers · 2026Article
- Glycolysis and glycolytic enzymes in acute myeloid leukemia: Warburg and beyond.Frontiers in pharmacology · 2026Review
- Tryptophan metabolism in tumor immune escape: mechanisms, cellular crosstalk, and therapeutic opportunities.Frontiers in immunology · 2026Review
- The microbiota-host metabolic axis in cervical cancer: from homeostatic disruption to mechanisms of therapy resistance.Frontiers in cellular and infection microbiology · 2026Review
- Combined analysis of metabolomics and transcriptomics reveals new indicators for the diagnosis and prognosis of colorectal cancer.Contemporary oncology (Poznan, Poland) · 2026Article
- Gut microbial metabolites in cancer immunomodulation.Molecular cancer · 2025Review
- Amino acid metabolic reprogramming drives pathogenesis and therapy in hematologic malignancies.Discover oncology · 2025Review
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Spatial metabolomics has revolutionized cancer research by offering unprecedented insights into the metabolic heterogeneity of the tumor microenvironment (TME). Unlike conventional metabolomics, which lacks spatial resolution, spatial metabolomics enables the visualization of metabolic interactions among cancer cells, stromal components, and immune cells within their native tissue context. Despite its growing significance, a systematic and visualized analysis of spatial metabolomics in cancer research remains lacking, particularly in the integration of multi-omics data and the standardization of methodologies for comprehensive tumor metabolic mapping. Objectives: This study aims to conduct a bibliometric analysis to systematically evaluate the development trends, key contributors, research hotspots, and future directions of spatial metabolomics in cancer research. Methods: A bibliometric approach was employed using data retrieved from the Web of Science Core Collection. Analytical tools such as VOSviewer and CiteSpace were utilized to visualize and assess co-citation networks, keyword co-occurrence, and institutional collaborations. Key metrics, including publication trends, authorship influence, country contributions, and journal impact, were analyzed to map the research landscape in this domain. Results: A total of 182 publications on spatial metabolomics in cancer research were identified over the past two decades, with a notable surge in research output beginning in 2018. The field has experienced accelerated growth, with an annual average of 40 publications since 2021, reflecting its increasing relevance in cancer studies. Among 28 contributing countries, China (n=53), the United States (n=35), Germany (n=18), and the United Kingdom (n=13) have been the most active contributors. China leads in publication volume, while the United States exhibits the highest citation impact, indicating significant research influence. International collaboration networks are particularly strong among the United States, Germany, and China, underscoring the global interest in this emerging field. Analysis of key authors and institutions identifies He Jiuming as the most prolific author and Song Xiaowei as the researcher with the highest average citations. Other influential authors include Abliz Zeper and Sun Chenglong. Leading research institutions driving advancements in this field include the Chinese Academy of Medical Sciences, Peking Union Medical College, Harvard Medical School, and Stanford University. Regarding journal impact, Nature Communications (n=11), Journal of Pharmaceutical Analysis (n=9), and Nature Methods (n=8) are the most active publishing platforms in this domain. Citation analysis reveals that Cell, BioEssays, and Genome Medicine are among the most highly cited journals, reflecting the interdisciplinary nature of spatial metabolomics research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.